Fiscal year ending 2023. Filed on May 14, 2024.
Co 1227 South Braddock Avenue
Pittsburgh, Pennsylvania 15218
Translational Research Cancer Cente (EIN: 83-1794049), also known as Translational Research Cancer, has filed an IRS Form 990 since fiscal year 2022. In its fiscal year 2023 IRS Form 990 filing, Translational Research Cancer Cente, a 501(c)(3) charitable organization, reported compensation for 8 employees. Among the employees shown here, the average compensation is $0.
Revenue
Expenses
Employee compensation
No board members were reported during this fiscal year.
Dissemination of information regarding the prevention, treatment, and cure of cancer, integrating cancer biology and tumor immunology. Promoting research, clinical collaborations, enhanced partnerships with industry, and training of the next generation of scientists.
Be the first to know when new IRS Form 990 data is published for this organization.